Skip to content
DataLookout
Menu

NCT06007404

Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents

StatusRecruiting
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 31 days later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary endpoints: details revised at 1 of 5 entries
    • Primary completion pushed from Oct 2026 to Dec 2026
    • Eligibility criteria shortened, about 10 words
    • Secondary endpoints: details revised at 2 of 2 entries
  2. Minor Primary completion moved earlier from Sep 2027 to Oct 2026v6
  3. Minor Eligibility criteria expanded, about 9 words
    • Study arms: 4 to 5
    v4
  4. Minor Eligibility criteria expanded, about 27 words
    • Study arms: 3 to 4
    v3
  5. Minor Start date changed from estimate of Sep 2023 to Sep 6, 2023v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Glucose (OGTT)
Timeframe: 120 minutes
Insulin (OGTT)
Timeframe: 120 minutes
Glucose (MMTT)
Timeframe: 180 minutes
Insulin (MMTT)
Timeframe: 180 minutes
Monocyte /macrophage populations by flow cytometry
Timeframe: 180 minutes

Secondary (2)

Free fatty acids (MMTT)
Triglycerides (MMTT)

Arms and interventions

Normal weight

BMI ≥ 5th percentile \& \< 85th percentile

Obese weight

BMI ≥ 95th percentile

PreDiabetes

HbA1c \> 5.7%

Type 2 Diabetes

Diagnosed with Type 2 Diabetes

Overweight

BMI \> 86th percentile and \<94th percentile

Sites

1 site in 1 country

  • University of MichiganAnn Arbor, Michigan, United States